Factors Predicting Iliac Metastasis and Overall Survival in Malignant Melanoma of the Lower Extremities

References

• Corr D. G., Brennan M. F. Extent of lymph node dissection in melanoma of the trunk or lower extremity. Arch Surg, 1989, 124: 162–166.
   Google Scholar
• zoltie N., Chapman P., Joss G. Is iliac node clearance necessary for stage II melanoma ? Plast Reconstr Surg, 1991, 88: 810–813.
   Google Scholar
• Strobbe L. J. A., Jonk A., Hart A. A. M., Nieweg O. E., Kroon B. B. R. Positive iliac and obturator nodes in melanoma: survival and prognostic factors. Ann Surg Oncol, 1999, 6: 255–262.
   Google Scholar
• Karakousis C. P., Driscoll D. L. Positive deep nodes in the groin and survival in malignant melanoma. Am J Surg, 1996, 171: 421422.
   Google Scholar
• Finck S. J., Giuliano A. E., Mann B. D., Morton D. L. Results of ilioinguinal dissection for stage II melanoma. Ann Surg, 1982, 196: 180–186.
   Google Scholar
• McCarthy J. G., Haagensen C. D., Herter F. P. The role of groin dissection in the management of melanoma of the lower extremity. Ann Surg, 1974, 179: 156–159.
   Google Scholar
• Singletary S. E., Shallenberger R., Guinee V. F. Surgical management of groin nodal metastases from primary melanoma of the lower extremity. Surg Gynecol Obstet, 1992, 174: 195–200.
   Google Scholar
• Balch C. M., Soong S., Ross M. I. et al. Long-term results of a multiinstitutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm). Intergroup Melanoma Surgical Trial. Ann Surg Oncol, 2000, 7: 87–97.
   Google Scholar
• Cascinelli N., Morabito A., Santinami M., MacKie R. M., Belli F. Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomised trial. WHO Melanoma Programme. Lancet, 1998, 351: 793–796.
   Google Scholar
• Beitsch P., Balch C. Operative morbidity and risk factor assessment in melanoma patients undergoing inguinal lymph node dissection. Am J Surg, 1992, 164: 462–465.
   Google Scholar
• Hughes T. M., A’Hern R. P., Thomas J. M. Prognosis and surgical management of patients with palpable inguinal lymph node metastases from melanoma. Br J Surg, 2000, 87: 892–901.
   Google Scholar
• Karakousis C. P., Driscoll D. L. Groin dissection in malignant melanoma. Br J Surg, 1994, 81: 1771–1774.
   Google Scholar
• Mann G. B., Coir D. G. Does the extent of operation influence the prognosis in patients with melanoma metastatic to inguinal nodes ? Ann Surg Oncol, 1999, 6: 263–271.
   Google Scholar
• Allan C. P., Hayes A. J., Thomas J. M. Ilioinguinal lymph node dissection for palpable metastatic melanoma to the groin. ANZ J Surg, 2008, 78: 982–986.
   Google Scholar
• Meyer T., Merkel S., Gohl J., Hohenberger W. Lymph node dissection for clinically evident lymph node metastases of malignant melanoma. Eur J Surg Oncol, 2002, 28: 424–430.
   Google Scholar
• Kretschmer L., Neumann C., Preusser K. P., Marsch W. C. Superficial inguinal and radical ilioinguinal lymph node dissection in patients with palpable melanoma metastases to the groin-an analysis of survival and local recurrence. Acta Oncol, 2001, 40: 72–78.
   Google Scholar
• Balch C. M., Soong S. J., Gershenwald J. E. et al. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol, 2001, 19: 3622–3634.
   Google Scholar
• Thomas J. M. Caution with sentinel node biopsy in cutaneous melanoma. Br J Surg, 2006, 93: 129–130.
   Google Scholar
• van Akkooi A. C., de Wilt J. H., Verhoef C. et al. Clinical relevance of melanoma micrometastases (<. 1 mm) in sentinel nodes: are these nodes to be considered negative ? Ann Oncol, 2006, 17: 1578–1585.
   Google Scholar
• Govindarajan A., Ghazarian D. M., McCready D. R. et al. Histological features of melanoma sentinel lymph node metastases associated with status of the completion lymphadenectomy and rate of subsequent relapse. Ann Surg Oncol, 2007, 14: 906–912.
   Google Scholar
• Morton D. L., Thompson J. F., Cochran A. J. et al. Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med, 2006, 355: 1307–1317.
   Google Scholar
• Phan G. Q., Messina J. L., Sondak V. K., Zager J. S. Sentinel lymph node biopsy for melanoma: indications and rationale. Cancer Control, 2009, 16: 234–239.
   Google Scholar
• O’Brien C. J., Petersen-Schaefer K., Stevens G. N. et al. Adjuvant radiotherapy following neck dissection and parotidectomy for metastatic malignant melanoma. Head Neck, 1997, 19: 589–594.
   Google Scholar
• Buzaid A. C., Ross M. I., Balch C. M., Soong S., McCarthy W. H., Tinoco L. et al. Critical analysis of the current American Joint Committee on Cancer staging system for cutaneous melanoma and proposal of a new staging system. J Clin Oncol, 1997, 15: 1039–1051.
   Google Scholar
• Coir D. G., Rogatko A., Brennan M. F. Prognostic factors in patients with melanoma metastatic to axillary or inguinal lymph nodes. A multivariate analysis. Ann Surg, 1991, 214: 627–636.
   Google Scholar
• Balch C. M., Soong S. J., Murad T. M., Ingalls A. L., Maddox W. A. A multifactorial analysis of melanoma. III. Prognostic factors in melanoma patients with lymph node metastases. Ann Surg, 1981, 193: 377–388.
   Google Scholar
• Slingluff C. L. Jr., Vollmer R., Seigler H. F. Stage II malignant melanoma: presentation of a prognostic model and an assessment of specific active immunotherapy in 1273 patients. J Surg Oncol, 1988, 39: 139–147.
   Google Scholar